com.atlassian.confluence.content.render.xhtml.migration.exceptions.UnknownMacroMigrationException: The macro 'datalayer.push(arguments);' is unknown.

Appendix 10.2 PRISMA ScR Extension Fillable Checklist

 



The below checklists can be downloaded for review authors to refer to when reporting scoping reviews to ensure they are in line with the PRISMA scoping reviews extension. 

 

 

 

 






Update: Implications of PRISMA 2020 for the reporting of Scoping Reviews

Currently, those that undertake Scoping Reviews are asked to use the PRISMA extension for Scoping Reviews reporting guidance.1 In 2021, the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement was updated from its 2009 version.2 The changes, whilst necessary to ensure increased transparency and rigour in reporting for systematic reviews, has had some implications for scoping reviews. Since the PRISMA 2020 statement, the following changes can be considered when reporting a scoping review using the PRISMA ScR (table 1):

Table 1: PRISMA- ScR with associated changes

SECTION

ITEM

PRISMA-ScR CHECKLIST ITEM

CHANGES TO CONSIDER SINCE PRISMA 2020

REPORTED ON PAGE #

 

TITLE

Title

1

Identify the report as a scoping review.



Click here to enter text.

 

ABSTRACT

Structured summary

2

Provide a structured summary that includes (as applicable): background, objectives, eligibility criteria, sources of evidence, charting methods, results, and conclusions that relate to the review questions and objectives.

Use the abstract reporting checklist (see Item 2 in PRISMA 2020)



Click here to enter text.

 

INTRODUCTION

Rationale

3

Describe the rationale for the review in the context of what is already known. Explain why the review questions/objectives lend themselves to a scoping review approach.



Click here to enter text.

Objectives

4

Provide an explicit statement of the questions and objectives being addressed with reference to their key elements (e.g., population or participants, concepts, and context) or other relevant key elements used to conceptualize the review questions and/or objectives.



Click here to enter text.

 

METHODS

Protocol and registration

5

Indicate whether a review protocol exists; state if and where it can be accessed (e.g., a Web address); and if available, provide registration information, including the registration number.

Report any protocol amendments (see item 24 in PRISMA 2020)



Click here to enter text.

Eligibility criteria

6

Specify characteristics of the sources of evidence used as eligibility criteria (e.g., years considered, language, and publication status), and provide a rationale.



Click here to enter text.

Information sources*

7

Describe all information sources in the search (e.g., databases with dates of coverage and contact with authors to identify additional sources), as well as the date the most recent search was executed.



Click here to enter text.

Search

8

Present the full electronic search strategy for at least 1 database, including any limits used, such that it could be repeated.

Include the full search strategies for all databases, registers, and websites (see item 7 in PRISMA 2020)

Click here to enter text.

Selection of sources of evidence†

9

State the process for selecting sources of evidence (i.e., screening and eligibility) included in the scoping review.

Describe if automation tools were used for study selection (see item 8 in PRISMA 2020)

Click here to enter text.

Data charting process‡

10

Describe the methods of charting data from the included sources of evidence (e.g., calibrated forms or forms that have been tested by the team before their use, and whether data charting was done independently or in duplicate) and any processes for obtaining and confirming data from investigators.

If outcomes were included, describe how they were defined and which results were sought (see item 10 in PRISMA 2020)



Click here to enter text.

Data items

11

List and define all variables for which data were sought and any assumptions and simplifications made.



Click here to enter text.

Critical appraisal of individual sources of evidence§

12

If done, provide a rationale for conducting a critical appraisal of included sources of evidence; describe the methods used and how this information was used in any data synthesis (if appropriate).



Click here to enter text.

Synthesis of results

13

Describe the methods of handling and summarizing the data that were charted.



Click here to enter text.

 

RESULTS

Selection of sources of evidence

14

Give numbers of sources of evidence screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally using a flow diagram.

Use the updated PRISMA 2020 flow diagram, which has optional boxes for review updates, as well as studies that were identified through means other than searching databases/registers and cite any studies that appeared to meet the inclusion criteria but were excluded (see item 16 in PRISMA 2020)

Click here to enter text.

Characteristics of sources of evidence

15

For each source of evidence, present characteristics for which data were charted and provide the citations.



Click here to enter text.

Critical appraisal within sources of evidence

16

If done, present data on critical appraisal of included sources of evidence (see item 12).



Click here to enter text.

Results of individual sources of evidence

17

For each included source of evidence, present the relevant data that were charted that relate to the review questions and objectives.



Click here to enter text.

Synthesis of results

18

Summarize and/or present the charting results as they relate to the review questions and objectives.



Click here to enter text.

 

DISCUSSION

Summary of evidence

19

Summarize the main results (including an overview of concepts, themes, and types of evidence available), link to the review questions and objectives, and consider the relevance to key groups.



Click here to enter text.

Limitations

20

Discuss the limitations of the scoping review process.



Click here to enter text.

Conclusions

21

Provide a general interpretation of the results with respect to the review questions and objectives, as well as potential implications and/or next steps.



Click here to enter text.

 

FUNDING

Funding

22

Describe sources of funding for the included sources of evidence, as well as sources of funding for the scoping review. Describe the role of the funders of the scoping review.

Report conflicts of interest (see item 26 in PRISMA 2020)

Click here to enter text.



OTHER CONSIDERATIONS

In addition, a new item was included in PRISMA 2020, which recommends reporting where data and other materials from the review are publicly available (see item 27 in PRISMA 2020), which can be included when reporting a scoping review.



* Where sources of evidence (see second footnote) are compiled from, such as bibliographic databases, social media platforms, and Web sites. † A more inclusive/heterogeneous term used to account for the different types of evidence or data sources (e.g., quantitative and/or qualitative research, expert opinion, and policy documents) that may be eligible in a scoping review as opposed to only studies. This is not to be confused with information sources (see first footnote). ‡ The frameworks by Arksey and O’Malley and Levac and colleagues refer to the process of data extraction in a scoping review as data charting. JBI Guidance uses the term data extraction. § The process of systematically examining research evidence to assess its validity, results, and relevance before using it to inform a decision. This term is used for items 12 and 19 instead of "risk of bias" (which is more applicable to systematic reviews of interventions) to include and acknowledge the various sources of evidence that may be used in a scoping review (e.g., quantitative and/or qualitative research, expert opinion, and policy document).

References

  1. Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Annals of Internal Medicine 2018; 169(7): 467-473.

  2. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71.